Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.

Morgenthaler TI, Kapur VK, Brown T, Swick TJ, Alessi C, Aurora RN, Boehlecke B, Chesson AL Jr, Friedman L, Maganti R, Owens J, Pancer J, Zak R; Standards of Practice Committee of the American Academy of Sleep Medicine.

Sleep. 2007 Dec;30(12):1705-11. Review. Erratum in: Sleep. 2008 Feb 1;31(2):table of contents.

2.

Treatment of narcolepsy and other hypersomnias of central origin.

Wise MS, Arand DL, Auger RR, Brooks SN, Watson NF; American Academy of Sleep Medicine.

Sleep. 2007 Dec;30(12):1712-27. Review.

3.

[Hypersomnia: a diagnostic problem].

Kranenburg G, Teunissen LL.

Ned Tijdschr Geneeskd. 2014;158:A7537. Review. Dutch.

PMID:
25096034
4.

EFNS guidelines on management of narcolepsy.

Billiard M, Bassetti C, Dauvilliers Y, Dolenc-Groselj L, Lammers GJ, Mayer G, Pollmächer T, Reading P, Sonka K; EFNS Task Force.

Eur J Neurol. 2006 Oct;13(10):1035-48.

PMID:
16987156
5.

Narcolepsy: treatment issues.

Roth T.

J Clin Psychiatry. 2007;68 Suppl 13:16-9.

6.

An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy.

Mignot E.

Sleep Med Rev. 2004 Oct;8(5):333-8. Review. No abstract available.

PMID:
15336234
7.

[Narcolepsy: etiology, clinical features, diagnosis and treatment].

Zawilska JB, Woldan-Tambor A, Płocka A, Kużajska K, Wojcieszak J.

Postepy Hig Med Dosw (Online). 2012 Oct 24;66:771-86. doi: 10.5604/17322693.1015529. Review. Polish.

8.

Diagnosis and management of central hypersomnias.

Sonka K, Susta M.

Ther Adv Neurol Disord. 2012 Sep;5(5):297-305. doi: 10.1177/1756285612454692.

9.

Emerging treatments for narcolepsy and its related disorders.

Nishino S, Okuro M.

Expert Opin Emerg Drugs. 2010 Mar;15(1):139-58. doi: 10.1517/14728210903559852. Review.

PMID:
20166851
10.

Modafinil: a second look. Confirmed efficacy in narcolepsy.

[No authors listed]

Prescrire Int. 1999 Feb;8(39):5-7.

PMID:
10557564
11.

Practice parameters for the treatment of narcolepsy: an update for 2000.

Littner M, Johnson SF, McCall WV, Anderson WM, Davila D, Hartse SK, Kushida CA, Wise MS, Hirshkowitz M, Woodson BT; Standards of Practice Committee.

Sleep. 2001 Jun 15;24(4):451-66.

PMID:
11403530
12.

[Narcolepsy and other hypersomnias].

Sand T, Schrader H.

Tidsskr Nor Laegeforen. 2009 Oct 8;129(19):2007-10. doi: 10.4045/tidsskr.08.0655. Review. Norwegian.

13.

Psychological health in central hypersomnias: the French Harmony study.

Dauvilliers Y, Paquereau J, Bastuji H, Drouot X, Weil JS, Viot-Blanc V.

J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):636-41. doi: 10.1136/jnnp.2008.161588. Epub 2009 Feb 11.

PMID:
19211597
14.

Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.

Lavault S, Dauvilliers Y, Drouot X, Leu-Semenescu S, Golmard JL, Lecendreux M, Franco P, Arnulf I.

Sleep Med. 2011 Jun;12(6):550-6. doi: 10.1016/j.sleep.2011.03.010. Epub 2011 May 14.

PMID:
21576035
15.

Therapeutic advances in narcolepsy.

Thorpy M.

Sleep Med. 2007 Jun;8(4):427-40. Epub 2007 May 1. Review.

PMID:
17475553
16.

CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.

Kanbayashi T, Kodama T, Kondo H, Satoh S, Inoue Y, Chiba S, Shimizu T, Nishino S.

Sleep. 2009 Feb;32(2):181-7.

17.

Pharmacotherapy for excessive daytime sleepiness.

Banerjee D, Vitiello MV, Grunstein RR.

Sleep Med Rev. 2004 Oct;8(5):339-54. Review.

PMID:
15336235
18.

Treatment of narcolepsy.

Didato G, Nobili L.

Expert Rev Neurother. 2009 Jun;9(6):897-910. doi: 10.1586/ern.09.29. Review.

PMID:
19496692
19.

Emerging drugs for narcolepsy.

Abad VC, Guilleminault C.

Expert Opin Emerg Drugs. 2004 Nov;9(2):281-91. Review.

PMID:
15571485
20.

Narcolepsy: pathophysiology and pharmacology.

Nishino S.

J Clin Psychiatry. 2007;68 Suppl 13:9-15. Review.

Supplemental Content

Support Center